219 related articles for article (PubMed ID: 19032081)
1. In silico functional profiling of small molecules and its applications.
Sato T; Matsuo Y; Honma T; Yokoyama S
J Med Chem; 2008 Dec; 51(24):7705-16. PubMed ID: 19032081
[TBL] [Abstract][Full Text] [Related]
2. CLEVER: pipeline for designing in silico chemical libraries.
Song CM; Bernardo PH; Chai CL; Tong JC
J Mol Graph Model; 2009 Jan; 27(5):578-83. PubMed ID: 18986817
[TBL] [Abstract][Full Text] [Related]
3. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
[TBL] [Abstract][Full Text] [Related]
4. Ligand-based approach to in silico pharmacology: nuclear receptor profiling.
Mestres J; Martín-Couce L; Gregori-Puigjané E; Cases M; Boyer S
J Chem Inf Model; 2006; 46(6):2725-36. PubMed ID: 17125212
[TBL] [Abstract][Full Text] [Related]
5. An integrated in silico analysis of drug-binding to human serum albumin.
Estrada E; Uriarte E; Molina E; Simón-Manso Y; Milne GW
J Chem Inf Model; 2006; 46(6):2709-24. PubMed ID: 17125211
[TBL] [Abstract][Full Text] [Related]
6. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
Rester U
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
[TBL] [Abstract][Full Text] [Related]
7. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in drug discovery and development.
Stratowa C; Wilgenbus KK
Curr Opin Mol Ther; 1999 Dec; 1(6):671-9. PubMed ID: 19629863
[TBL] [Abstract][Full Text] [Related]
9. Beyond profiling: using ADMET models to guide decisions.
Segall M; Champness E; Obrezanova O; Leeding C
Chem Biodivers; 2009 Nov; 6(11):2144-51. PubMed ID: 19937845
[TBL] [Abstract][Full Text] [Related]
10. Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion.
Wang J; Krudy G; Xie XQ; Wu C; Holland G
J Chem Inf Model; 2006; 46(6):2674-83. PubMed ID: 17125207
[TBL] [Abstract][Full Text] [Related]
11. Application of molecular topology to the prediction of the antimalarial activity of a group of uracil-based acyclic and deoxyuridine compounds.
García-Domenech R; López-Peña W; Sanchez-Perdomo Y; Sanders JR; Sierra-Araujo MM; Zapata C; Gálvez J
Int J Pharm; 2008 Nov; 363(1-2):78-84. PubMed ID: 18675892
[TBL] [Abstract][Full Text] [Related]
12. Prediction of pH-dependent aqueous solubility of druglike molecules.
Hansen NT; Kouskoumvekaki I; Jørgensen FS; Brunak S; Jónsdóttir SO
J Chem Inf Model; 2006; 46(6):2601-9. PubMed ID: 17125200
[TBL] [Abstract][Full Text] [Related]
13. Applications of self-organizing neural networks in virtual screening and diversity selection.
Selzer P; Ertl P
J Chem Inf Model; 2006; 46(6):2319-23. PubMed ID: 17125175
[TBL] [Abstract][Full Text] [Related]
14. Ultrafast shape recognition: evaluating a new ligand-based virtual screening technology.
Ballester PJ; Finn PW; Richards WG
J Mol Graph Model; 2009 Apr; 27(7):836-45. PubMed ID: 19188082
[TBL] [Abstract][Full Text] [Related]
15. NIPALSTREE: a new hierarchical clustering approach for large compound libraries and its application to virtual screening.
Böcker A; Schneider G; Teckentrup A
J Chem Inf Model; 2006; 46(6):2220-9. PubMed ID: 17125166
[TBL] [Abstract][Full Text] [Related]
16. In silico classification of adenosine receptor antagonists using Laplacian-modified naïve Bayesian, support vector machine, and recursive partitioning.
Lee JH; Lee S; Choi S
J Mol Graph Model; 2010 Jun; 28(8):883-90. PubMed ID: 20447849
[TBL] [Abstract][Full Text] [Related]
17. Combining cluster analysis, feature selection and multiple support vector machine models for the identification of human ether-a-go-go related gene channel blocking compounds.
Nisius B; Göller AH; Bajorath J
Chem Biol Drug Des; 2009 Jan; 73(1):17-25. PubMed ID: 19152631
[TBL] [Abstract][Full Text] [Related]
18. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
[TBL] [Abstract][Full Text] [Related]
19. The molecule evoluator. An interactive evolutionary algorithm for the design of drug-like molecules.
Lameijer EW; Kok JN; Bäck T; Ijzerman AP
J Chem Inf Model; 2006; 46(2):545-52. PubMed ID: 16562982
[TBL] [Abstract][Full Text] [Related]
20. A cluster-based strategy for assessing the overlap between large chemical libraries and its application to a recent acquisition.
Engels MF; Gibbs AC; Jaeger EP; Verbinnen D; Lobanov VS; Agrafiotis DK
J Chem Inf Model; 2006; 46(6):2651-60. PubMed ID: 17125205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
